Data as of Sep 12, 2026. Both funds on the fields they both publish, from the same sources.
EMB vs XLV: how they differ
EMB and XLV hold 0% of their weight in the same names, and XLV returned more over the year.
iShares J.P. Morgan USD Emerging Markets Bond ETF and State Street(R) Health Care Select Sector SPDR(R) ETF.
What they hold in common
By the books each fund has filed, EMB and XLV hold 0% of their money in the same securities at the same weight.
| Only in EMB | Only in XLV |
|---|---|
| Argentina Republic Government Internatio 1.12% | Eli Lilly & Co 16.56% |
| Argentina Republic Government Internatio 0.73% | Johnson & Johnson 10.67% |
| Argentina Republic Government Internatio 0.64% | AbbVie Inc 7.76% |
| Argentina Republic Government Internatio 0.53% | UnitedHealth Group Inc 6.59% |
| Uruguay Government International Bonds 0.52% | Merck & Co Inc 5.54% |
| EAGLE FUNDING LUXCO SARL 0.51% | Amgen Inc 3.41% |
| Republic of Poland Government Internatio 0.40% | Thermo Fisher Scientific Inc 3.25% |
| UKRAINE GOVERNMENT 0.38% | Abbott Laboratories 2.76% |
Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed. Above 50%, holding both is close to holding one of them twice. Holdings dated Apr 30, 2026 and Jun 30, 2026.
| EMB iShares J.P. Morgan USD Emerging Markets Bond ETF | XLV State Street(R) Health Care Select Sector SPDR(R) ETF | |
|---|---|---|
| Where it sits | Core index fund | Core index fund |
| Issuer | iShares | State Street |
| What it is | J.P. Morgan USD Emerging Markets Bond | Health care |
| Total return, 1 year | +2.8% | +20.4% |
| S&P 500 over the same days | +17.5% | +17.5% |
| Gap to the S&P 500 | −14.7 pts | +2.9 pts |
| Expense ratio | 0.39% | 0.08% |
| Holdings | 681 | 59 |
EMB in plain words
EMB is a bond fund tracking the J.P. Morgan USD Emerging Markets Bond. Over the year to Sep 11, 2026 it returned +2.8% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.39% a year.
XLV in plain words
XLV is an index equity fund tracking the Health care. Over the year to Sep 11, 2026 it returned +20.4% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.08% a year. By its holdings filed for Jun 30, 2026, 100% of the fund by weight is stocks the S&P 500 also holds, across 59 positions, with the top ten at 61.7%. It sat 5.9% below its high of Aug 19, 2026 on Sep 11, 2026.
Questions people ask
- Which returned more over the last year, EMB or XLV?
- In the year to Sep 12, 2026, with distributions reinvested, EMB returned +2.8% and XLV returned +20.4%, so XLV returned more. One year is one year; the longer windows are in the table.
- Which is cheaper, EMB or XLV?
- EMB charges 0.39% a year and XLV charges 0.08%, so XLV is cheaper. Fees come from each fund's prospectus.
Other comparisons
Where to next
Where these figures came from
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.
Cite this page. ETFIQ, EMB against XLV, data as of Sep 12, 2026. https://etfiq.com/compare/any/EMB-XLV Free to use with attribution; the underlying files are at Open data.
A comparison is not a recommendation. Standards and sources